Tradestie Institutional Equity Comparison Engine
SDEV vs APUS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
APUS Overall Edge
APUS Captures Institutional Edge (2โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Apimeds Pharmaceuticals US, Inc. (APUS) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, SDEV trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus APUS at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SDEV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against APUS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SDEV N/M vs APUS N/M Fwd P/E
Growth & Margin Winner
APUS
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
APUS
1Y -62.4% vs +7.2% ยท 52W Pos 0% vs 16%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SDEV
US Equity
SDEV
Institutional Equity
$0.71
-9.42% 1D
Market Cap
N/A
1M Return
-19.79%
1Y Return
-62.42%
Forward P/E
N/M
Unified AI Score
45.8 / 100
HOLD
Tech 43.0
Fund 46.0
Flow 50.0
Mom 50.0
APUS
NYSE American
Apimeds Pharmaceuticals US, Inc.
Pharmaceutical Preparations
$2.05
-7.91% 1D
Market Cap
$3.4M
1M Return
-49.17%
1Y Return
+7.18%
Forward P/E
N/M
Unified AI Score
48.5 / 100
HOLD
Tech 43.0
Fund 49.0
Flow 50.0
Mom 70.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SDEV -62.42%
APUS +7.18%
Spread: +19.04 pp (APUS Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SDEV TTM Op. Margin: N/A
APUS TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SDEV vs APUS. Trailing 12-month operating profitability (SDEV N/A vs APUS 0.0%) and valuation multiples (SDEV N/M vs APUS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SDEV | APUS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $3.4M | Larger Scale | APUS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | APUS |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | APUS |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | APUS |
| Return on Equity (ROE) Capital Efficiency | N/A | 0.0% | Higher ROE | APUS |
| 52-Week Range Position Momentum | 0% ($1โ$10) | 16% ($1โ$10) | Stronger Trend | APUS |
| Beta / 30D Volatility Risk Regime | 1.47ฮฒ ยท 154% Vol | 2.97ฮฒ ยท 67% Vol | Lower Realized Risk | APUS |
| Unified Institutional Score Composite Signal | 45.8 / 100 (HOLD) | 48.5 / 100 (HOLD) | Higher Composite | APUS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SDEV vs APUS Buy Guide
SDEV
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
APUS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SDEV nor APUS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.